Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

 2,390.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 3,170.00
  • 52 Week Low: 1,966.00
  • Currency: UK Pounds
  • Shares Issued: 65.12m
  • Volume: 138,481
  • Market Cap: £1,556.46m
  • RiskGrade: 128
  • Beta: 0.01

Latest ShareCast News

Genus announces £60m buyback as FY profits rise but shares drop on revenue miss

By Michele Maatouk

Date: Thursday 10 Sep 2026

(Sharecast News) - Animal genetics firm Genus reported a rise in full-year profit on Thursday and announced a £60m share buyback, but shares slumped as revenue missed expectations.

Genus Regulatory News

Holding(s) in Company 05-Nov-2026 14:21 RNS
Total Voting Rights 02-Nov-2026 11:43 RNS
Transaction in Own Shares 02-Nov-2026 07:00 RNS
Transaction in Own Shares 26-Oct-2026 07:00 RNS
Transaction in Own Shares 19-Oct-2026 07:00 RNS

Genus News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genus Market Data

Currency UK Pounds
Share Price 2,390.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 3,170.00
52 Week Low 1,966.00
Volume 138,481
Shares Issued 65.12m
Market Cap £1,556.46m
Beta 0.01
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
97.47% below the market average97.47% below the market average97.47% below the market average97.47% below the market average97.47% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
63.96% above the market average63.96% above the market average63.96% above the market average63.96% above the market average63.96% above the market average
44.19% above the sector average44.19% above the sector average44.19% above the sector average44.19% above the sector average44.19% above the sector average
Income
92.5% below the market average92.5% below the market average92.5% below the market average92.5% below the market average92.5% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Growth
73.38% above the market average73.38% above the market average73.38% above the market average73.38% above the market average73.38% above the market average
85.71% above the sector average85.71% above the sector average85.71% above the sector average85.71% above the sector average85.71% above the sector average

What The Brokers Say

Strong Buy 6
Buy 2
Neutral 1
Sell 0
Strong Sell 0
Total 9
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Final Interim
Ex-Div 12-Nov-26 05-Mar-26
Paid 04-Dec-26 27-Mar-26
Amount 24.00p 11.20p

Trades for 05-Nov-2026

Time Volume / Share Price
16:32 31,471 @ 2,419.32p
16:29 82 @ 2,392.00p
16:29 82 @ 2,396.00p
16:29 82 @ 2,396.00p
16:29 22 @ 2,396.00p

Genus Key Personnel

CEO Jorgen Kokke
CFO Andy Russell

Top of Page